<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02466256</url>
  </required_header>
  <id_info>
    <org_study_id>2014-005</org_study_id>
    <nct_id>NCT02466256</nct_id>
  </id_info>
  <brief_title>Intra and Postoperative Outcomes With 3 Injectors</brief_title>
  <official_title>Comparison of Intraoperative Performance and Incision Morphology Using Three Injector Devices : Randomized, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iladevi Cataract and IOL Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iladevi Cataract and IOL Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial compares subjective performance during Intraocular lens (IOL)
      implantation, as well as incision enlargement and anterior segment morphology on OCT when IOL
      implantation was performed during microcoaxial phacoemulsification through a 2.2mm incision
      using one of three injectors :

      Manual screw type (Monarch III), Manual plunger type (Royale) and motorised injector
      (Autosert). Further, the investigators also looked at incision integrity by comparing ingress
      of trypan blue from the ocular surface into the anterior chamber.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized, clinical trial, three types of injectors were compared :

        1. Manual, screw type injector (Monarch III)

        2. Manual, plunger type injector (Royale, ASICO)

        3. Motorized injector (Autosert, Alcon)

      Having performed a phacoemulsification through 2.2mm incision, IOL implantation was performed
      using a D cartridge and one of three injectors which was decided in a randomized fashion.

      The investigators evaluated incision enlargement at following points : at the end of
      phacoemulsification, and then, at the end of IOL implantation The investigators also looked
      at trypan blue ingress into the anterior chamber from the ocular surface. At 1 day, 1 week,
      and 1 month after surgery anterior segment OCT morphology was also studied.

      further, the surgeon was asked to subjectively grade the ease of implantation with each
      injector
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incision enlargement in mm</measure>
    <time_frame>1 minute after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trypan Blue ingress into the anterior chamber in log units</measure>
    <time_frame>1 minute after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incision morphology - qualitative</measure>
    <time_frame>1 day, 1 week and 1 month after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Autosert Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Procedure / Surgery : Intraocular lens implantation with Autosert injector</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Royale Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Procedure / Surgery : Intraocular lens implantation with Royale Injector</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monarch III Injector</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Procedure / Surgery : Intraocular lens implantation with Monarch III group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraocular lens implantation</intervention_name>
    <description>Intraocular lens implantation</description>
    <arm_group_label>Autosert Group</arm_group_label>
    <arm_group_label>Royale Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autosert Injector</intervention_name>
    <description>Motorised injection device for intraocular lens implantation</description>
    <arm_group_label>Autosert Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Royale Injector</intervention_name>
    <description>Manual, plunger type injection device for intraocular lens implantation</description>
    <arm_group_label>Royale Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Monarch III Injector</intervention_name>
    <description>Manual, screw type injection device for intraocular lens implantation</description>
    <arm_group_label>Monarch III Injector</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing phacoemulsification for age-related uncomplicated cataracts
             through a 2.2mm incision.

          -  Nuclear or corticonuclear of grade 2 to 4 according to the Lens Opacities
             Classification System (LOCS III)

        Exclusion Criteria:

          -  Glaucoma,

          -  uveitis,

          -  shallow anterior chamber (depth &lt;2.1mm),

          -  prior ocular trauma or surgery,

          -  maximal pupillary dilatation &lt;6mm,

          -  high myopia (axial length &gt;25mm),

          -  posterior polar cataracts,

          -  dense cataracts, and

          -  an IOL power &lt;19.0 D or &gt;25.0 D
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>abhay r vasavada, ms, frcs</last_name>
    <role>Principal Investigator</role>
    <affiliation>iladevi cataract &amp; iol research centre</affiliation>
  </overall_official>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2015</study_first_submitted>
  <study_first_submitted_qc>June 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2015</study_first_posted>
  <last_update_submitted>June 8, 2015</last_update_submitted>
  <last_update_submitted_qc>June 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Iladevi Cataract and IOL Research Center</investigator_affiliation>
    <investigator_full_name>Abhay R. Vasavada</investigator_full_name>
    <investigator_title>M.S., F.R.C.S (England)</investigator_title>
  </responsible_party>
  <keyword>Intraocular lens implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

